Human leukocyte antigen e in human cytomegalovirus infection: Friend or foe?

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 7, 2012, Pages 551-554

  Gong, Fang ^a   Song, Shengli ^b   Lv, Guozhong ^a   Pan, Yuhong ^a   Zhang, Dongqing ^b   Jiang, Hong ^b  

^a NANTONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

cytomegalovirus; human leukocyte antigen E; major histocompatibility Ib

Indexed keywords

HLA ANTIGEN CLASS 1; HLA E ANTIGEN; HLA-E ANTIGEN; KLRD1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY D; SIGNAL PEPTIDE; UL40 GLYCOPROTEIN, CYTOMEGALOVIRUS; VIRUS PROTEIN;

BIOLOGICAL MODEL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNOLOGY; METABOLISM; NATURAL KILLER CELL; PROTEIN BINDING; REVIEW; VIROLOGY;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; MODELS, IMMUNOLOGICAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; PROTEIN BINDING; PROTEIN SORTING SIGNALS; VIRAL PROTEINS;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 84863437247     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms032     Document Type: Review

References (37)

1. Griffin BD, Verweij MC and Wiertz EJ. Herpesviruses and immunity: The art of evasion. Vet Microbiol 2010, 143: 89-100.
2. Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S and Cerundolo V, et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000, 287: 1031.
3. Ulbrecht M, Hofmeister V, Yuksekdag G, Ellwart JW, Hengel H, Momburg F and Martinozzi S, et al. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. Hum Immunol 2003, 64: 231-237.
4. Misaghi S, Sun ZY, Stern P, Gaudet R, Wagner G and Ploegh H. Structural and functional analysis of human cytomegalovirus US3 protein. J Virol 2004, 78: 413-423.
5. Liu Z, Winkler M and Biegalke B. Human cytomegalovirus: Host immune modulation by the viral US3 gene. Int J Biochem Cell Biol 2009, 41: 503-506.
6. Dugan GE and Hewitt EW. Dependence of the localization and function of the human cytomegalovirus protein US6 on the transporter associated with antigen processing. J Gen Virol 2009, 90: 2234-2238.
7. Dugan GE and Hewitt EW. Structural and functional dissection of the human cytomegalovirus immune evasion protein US6. J Virol 2008, 2: 3271-3282.
8. Furman MH, Dey N, Tortorella D and Ploegh HL. The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. J Virol 2002, 76: 11753-11756.
9. Park B, Spooner E, Houser BL, Strominger JL and Ploegh HL. The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J Exp Med 2010, 207: 2033-2041.
10. Barel MT, Pizzato N, Van Leeuwen D, Bouteiller PL, Wiertz EJ and Lenfant F. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated downregulation. Eur J Immunol 2003, 33: 1707-1716.
11. Strong RK, Holmes MA, Li P, Braun L, Lee N and Geraghty DE. HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 2003, 278: 5082-5090.
12. Lee N, Goodlett DR, Ishitani A, Marquardt H and Geraghty DE. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 1998, 160: 4951-4960.
13. Michaelsson J, Teixeira De Matos C, Achour A, Lanier LL, Karre K and Soderstrom K. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med 2002, 196: 1403-1414.
14. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS and Lazetic S, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998, 391: 795-799.
15. Yokoyama WM and Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003, 3: 304-316.
16. Vales-Gomez M, Reyburn HT, Erskine RA, Lopez-Botet M and Strominger JL. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 1999, 18: 4250-4260.
17. Lu L, Werneck MB and Cantor H. The immunoregulatory effects of Qa-1. Immunol Rev 2006, 212: 51-59.
18. Joosten SA, Van Meijgaarden KE, Van Weeren PC, Kazi F, Geluk A, Savage ND and Drijfhout JW, et al. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity. PLoS Pathog 2010, 6: E1000782.
19. Heinzel AS, Grotzke JE, Lines RA, Lewinsohn DA, McNabb AL, Streblow DN and Braud VM, et al. HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. J Exp Med 2002, 196: 1473-1481.
20. Romagnani C, Pietra G, Falco M, Mazzarino P, Moretta L and Mingari MC. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes. Hum Immunol 2004, 65: 437-445.
21. Pietra G, Romagnani C, Mazzarino P, Falco M, Millo E, Moretta A and Moretta L, et al. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci U S A 2003, 100: 10896-10901.
22. Mazzarino P, Pietra G, Vacca P, Falco M, Colau D, Coulie P and Moretta L, et al. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion. Eur J Immunol 2005, 35: 3240-3247.
23. Salerno-Goncalves R, Fernandez-Vina M, Lewinsohn DM and Sztein MB. Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J Immunol 2004, 173: 5852-5862.
24. Jiang H and Chess L. Qa-1 restricted CD8 Treg and self-nonself discrimination-An essay on peripheral T-cell regulation. Hum Immunol 2008, 69: 721-727.
25. Orange JS, Fassett MS, Koopman LA, Boyson JE and Strominger JL. Viral evasion of natural killer cells. Nat Immunol 2002, 3: 1006-1012.
26. Revilleza MJ, Wang R, Mans J, Hong M, Natarajan K and Margulies DH. How the virus outsmarts the host: Function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance. J Biomed Biotechnol 2011, 2011: 724607.
27. Vermijlen D, Brouwer M, Donner C, Liesnard C, Tackoen M, Van Rysselberge M and Twité N, et al. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med 2010, 207: 807-821.
28. Ulbrecht M, Martinozzi S, Grzeschik M, Hengel H, Ellwart JW, Pla M and Weiss EH. Cutting edge: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J Immunol 2000, 164: 5019-5022.
29. Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK and Braud VM, et al. UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc Natl Acad Sci U S A 2002, 99: 7570-7575.
30. Barel MT, Pizzato N, Le Bouteiller P, Wiertz EJ and Lenfant F. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation. Int Immunol 2006, 18: 173-182.
31. Prod'homme V, Tomasec P, Cunningham C, Lemberg MK, Stanton RJ, McSharry BP and Wang EC, et al. Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18. J Immunol 2012, 188: 2794-2804.
32. Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N and Lopez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004, 104: 3664-3671.
33. Monsiváis-Urenda A, Noyola-Cherpitel D, Hernández-Salinas A, García-Sepúlveda C, Romo N, Baranda L and López-Botet M, et al. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur J Immunol 2010, 40: 1418-1427.
34. Beziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A and Hervier B, et al. CMV drives clonal expansion of highly differentiated NKG2C(+) NK cells expressing self-specific KIRs in patients with chronic hepatitis virus infection. Eur J Immunol 2011, 42: 447-457.
35. Lopez-Vergès S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA and Houchins JP, et al. Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A 2011, 108: 14725-14732.
36. Guma M, Budt M, Saez A, Brckalo T, Hengel H, Angulo A and Lopez-Botet M. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006, 107: 3624-3631.
37. Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X and Lopez-Vergès S, et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2012, 119: 2665-2674.